ProQR Therapeutics
PRQR
PRQR
76 hedge funds and large institutions have $118M invested in ProQR Therapeutics in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
62% more funds holding
Funds holding: 47 → 76 (+29)
21.69% more ownership
Funds ownership: 21.36% → 43.05% (+22%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
76
Holding in Top 10
2
Calls
$296K
Puts
$163K
Top Buyers
| 1 | +$15.8M | |
| 2 | +$9.43M | |
| 3 | +$7.49M | |
| 4 |
Millennium Management
New York
|
+$7.11M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.11M |
Top Sellers
| 1 | -$3.34M | |
| 2 | -$1.71M | |
| 3 | -$880K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$750K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$165K |